Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-989-5 | CAS number: 732-26-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
ORAL
A single acute toxicity study is currently available in which the acute oral LD50 of the substance was determined to be >200 mg/kg in the rat.
DERMAL
A single acute toxicity study is currently available in which the acute dermal LD50 of the substance was determined to exceed 2000 mg/kg in the rat.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 200 mg/kg bw
- Quality of whole database:
- A single study of reliability K2 is available to address this endpoint. The quality of the database is therefore considered to be good.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- A single study of reliability K1 is available to address this endpoint. The quality of the database is therefore considered to be high.
Additional information
Oral
A single acute toxicity study is currently available as a part of the data set on this substance. It has been assigned a reliability score of 2 according to the criteria of Klimisch et al. (1997) and has therefore been used for chemical safety assessment. In this study the acute toxicity potential of the test material was investigated in a study conducted in accordance with the standardised guidelines OECD 401 and EU Method B.1 under GLP conditions. A group of ten fasted Sprague-Dawley rats (five males and five females) was given a single oral dose of the test material as a suspension in arachis oil B.P. at a dose level of 2000 mg/kg bodyweight. An additional group of ten fasted animals was then treated with the test material administered as a suspension in arachis oil B.P. a t a dose level of 200 mg/kg bodyweight. The surviving animals were observed for fourteen days. All animals were subjected to a gross pathological examination. Two females treated with 2000 mg/kg were found dead one day after dosing. Four animals (one male and three females) in this group were killed in extremis one or four days after dosing. Common signs of systemic toxicity noted in this group were ataxia, hunched posture, lethargy, decreased respiratory rate and laboured respiration with additional signs of ptosis and loss of righting reflex. Surviving animals in this group recovered three or ten days after dosing. There were no deaths or signs of systemic toxicity noted in animals treated with 200 mg/kg. One male treated with 2000 mg/kg showed a slightly reduced gain in bodyweight during week one. All other surviving animals showed the expected gain in bodyweight during the study. Abnormalities noted at necropsy of animals that died or were killed in extremis during the study were haemorrhagic lungs, dark or pale liver, patchy pallor of the liver or red-coloured possible necrosis of the liver and haemorrhagic or pale gastric mucosa. No abnormalities were noted at necropsy of one female treated with 2000 mg/kg that was killed in extremis during the study, four males treated with 2000 mg/kg and animals treated with 200 mg/kg that were sacrificed at the end of the study. Under the conditions of this study the LD50 was found to be greater than 200 mg/kg bw but less than 2000 mg/kg bw.
Dermal
A single acute toxicity study is currently available as a part of the data set on this substance. It has been assigned a reliability score of 1 according to the criteria of Klimisch et al. (1997) and has therefore been used for chemical safety assessment.
The potential of the test material to cause acute dermal toxicity in the rat was investigated in accordance with the standardised guidelines OECD 402, EU Method B.3, US EPA OPPTS 870.1200 and JMAFF 12 Nousan, Notification No 8147 under GLP conditions.
The test material was administered to five Wistar rats of each sex by a single dermal application in an occlusive fashion at a limit dose of 2000 mg/kg body weight for 24 hours. After the exposure period, dressings were removed and the skin cleaned of residual test material using tap water. Animals were subjected to daily observations and weekly determination of body weight. Macroscopic examination was performed after terminal sacrifice (Day 15). No mortality occurred and there were no clinical signs noted for the animals. However, general erythema was noted for one female animal on Day 2. The changes noted in body weight gain in males and females were within the range expected for rats used in this type of study and were therefore considered not indicative of toxicity.
No abnormalities were found at macroscopic post mortem examination of the animals.
Under the conditions of this study the LD50 value was found to exceed 2000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
A single study assessing this endpoint was available. As such the results of this study have been used for chemical safety assessment.
Justification for selection of acute toxicity – dermal endpoint
A single study assessing this endpoint was available. As such the results of this study have been used for chemical safety assessment.
Justification for classification or non-classification
Oral
Under the conditions of the available study (Tuffnell, 1992), the LD50 of the substance was determined to be between 200 and 2000 mg/kg. In the absence of information to the contrary and as a worst case scenario, the substance has been determined to require classification in accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008 as Acute toxicity: Category 3 via the oral route and will be assigned the Hazard Statement H301: Toxic if swallowed.
Dermal
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Ce site web utilise des cookies afin de vous garantir la meilleure expérience possible sur nos sites web.